Bordetella parapertussis evolved in a host population that had already developed immunity to "B. pertussis", where being able to evade "B. pertussis" immunity was an advantage. Two lineages of "B. parapertussis" have been described. The first infects humans and is responsible for a minority of cases of the disease pertussis (also known as whooping cough). The second, ovine, lineage causes chronic nonprogressive pneumonia in sheep. Both lineages are thought to have evolved from a "B. bronchiseptica"-like ancestor. This disease can be symptomatic or asymptomatic and may predispose hosts to secondary infection. Bordetella parapertussis Bordetella parapertussis is a small Gram-negative bacterium of the
Fabry disease his classic paper on his electron microscopic findings in Fabry disease in 1965. The first specific treatment for Fabry disease was approved in 2001. Fabry disease Fabry disease, also known as Anderson–Fabry disease, is a rare genetic disease that can affect many parts of the body including the kidneys, heart, and skin. Fabry disease is one of a group of conditions known as lysosomal storage diseases. The genetic mutation that causes Fabry disease interferes with the function of an enzyme which processes biomolecules known as sphingolipids, leading to these substances building up in the walls of blood vessels and other